Ramdev Released Research Paper On Coronil

New Delhi : Yoga Guru Ramdev, the founder of Patanjali, released the first scientific research paper on the evidence-based medicine for COVID-19 by his organization. Union Health Minister, Dr Harsh Vardhan, and Union Minister Nitin Gadkari were also present at the event.

The medicine for which the data has been released is named Coronil. In June last year, Patanjali claimed that its Ayurvedic medicine can cure coronavirus infection. Following some controversy on the claims, Patanjali’s Coronil Kit was licensed as an ‘immunity booster’.

Swami Ramdev, at the event, said, that people believe that research work can only be conducted in the West. Especially when it comes to Ayurveda, people look at research work with suspicion. He also said that Coronil has benefited lakhs of people during the pandemic.

In June 2020, Patanjali Ayurved had launched ‘Coronil and Swasari’, which the company claimed was the first Ayurvedic cure for COVID-19, the respiratory disease caused by the novel coronavirus or SARS-CoV-2 virus. Launching a kit of three Ayurvedic medicines at Patanjali Yogpeeth in Haridwar, Uttarakhand, Yoga guru Ramdev had said they are proud to announce that the first Ayurvedic, clinically controlled trial based evidence and research-based medicine has been prepared by the combined efforts of Patanjali Research Centre and NIMS.

Ramdev had also said that the medicine could provide ‘100 per cent recovery rate within 3-7 days’.

  • Related Posts

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert